Related Experiment Video
Updated: Jul 18, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Constitutive phosphorylation of Janus kinase 2 in the GL15 glioblastoma derived human cell line
Miriam Sciaccaluga1, Gian Luigi Gianfranceschi, Simone Rocco
1Department of Cellular and Environmental Biology, Section of Cellular and Molecular Biology, University of Perugia, via Pascoli, 06100 Perugia, Italy.
Abstract:
The notion that gliomas could originate from mutated glial precursor cells highlights the possibility of modulating the proliferative and migratory behaviour of glioma cells by acting on the molecular mechanisms operative during the development of the Central Nervous System (CNS), but absent in the normal adult brain. We show that the GL15 glioblastoma derived human cell line displays a high expression of nestin which, combined with the previously demonstrated high expression of vimentin, constitutes a characteristic of astrocyte restricted precursors. We also show that, in analogy with some leukaemia cells, GL15 cells display the constitutively phosphorylated form of Janus kinase 2 (JAK2), a tyrosine kinase expressed during CNS development but undetectable in the normal adult brain. The constitutive activation of JAK2 does not result from chromosomal aberrations involving the JAK2 gene, but most probably from abnormally activated transduction systems operative in glioblastoma cells. We then investigated the effects of tyrphostin AG490, an inhibitor of JAK2 autophosphorylation, on GL15 cell growth. In the absence of exogenous growth factors and cytokines, 10 microM tyrphostin AG490 induces an S phase arrest, combined with a partial impairment of the G2 phase of the cell cycle. The abnormally activated JAK2 could then potentially represent a target for a selective pharmacological approach in glioblastoma cells in which a combination of glial precursor characteristics and genetic alterations occurs.
Insights
This study identifies Janus kinase 2 (JAK2) as constitutively active in glioblastoma cells, suggesting it as a potential therapeutic target. Inhibiting JAK2 with tyrphostin AG490 halts glioma cell cycle progression.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cell Biology
Background:
- Gliomas may arise from mutated glial precursor cells.
- Modulating developmental CNS pathways could impact glioma behavior.
- GL15 glioblastoma cells express nestin and vimentin, characteristic of astrocyte precursors.
Purpose of the Study:
- Investigate molecular mechanisms in glioblastoma cells.
- Determine the role of Janus kinase 2 (JAK2) in GL15 cells.
- Evaluate the effect of JAK2 inhibition on glioma cell proliferation.
Main Methods:
- Analyzed nestin and vimentin expression in GL15 cells.
- Assessed JAK2 phosphorylation status in GL15 cells.
- Treated GL15 cells with tyrphostin AG490 and analyzed cell cycle progression.
Main Results:
- GL15 cells exhibit characteristics of astrocyte restricted precursors.
- GL15 cells display constitutively phosphorylated JAK2, not due to chromosomal aberrations.
- Tyrphostin AG490 induced S phase arrest and G2 phase impairment in GL15 cells.
Conclusions:
- Abnormally activated JAK2 in glioblastoma cells presents a potential therapeutic target.
- JAK2 inhibition offers a selective pharmacological approach for specific glioblastomas.
- Targeting JAK2 may be effective in glioblastomas with precursor cell features and genetic alterations.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
